Overexpression of BCRP renders cancer cells resistant to multiple drugs such as mitoxantrone, topotecan, and methotrexate and is associated with poor response to chemotherapy in leukemia and breast cancer patients [69]. This evidence concerns the gene ABCG2 and cancer.